Point72 Middle East FZE’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,164
Closed -$59.8K 957
2023
Q4
$59.8K Buy
+5,164
New +$58.3K ﹤0.01% 1259

Other funds holding PAHC

Point72 Middle East FZE's PAHC Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Phibro Animal Health (PAHC) in Q1 2024, closing a stake of 5,164 shares — an estimated $59.8K sold.

Point72 Middle East FZE first reported a position in PAHC in Q4 2023 and held it in 1 quarter. The position peaked at $59.8K in Q4 2023. 138 funds tracked by Wall St. Rank hold PAHC as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Phibro Animal Health position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 5,164 Phibro Animal Health shares in Q1 2024, an estimated $59.8K.
  • Point72 Middle East FZE first reported a position in Phibro Animal Health in Q4 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's Phibro Animal Health position peaked at $59.8K in Q4 2023.
  • 138 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.